ArticleMolecules (Basel, Switzerland)2022
The Effect of Nano-ZnO on Seeds Germination Parameters of Different Tomatoes (
Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Insights into Salinity Stress-Induced Morpho-Physiological and Molecular Responses and Nanoparticle- and Nanobiochar-Mediated Tolerance Mechanisms During Seed Germination.Nanomaterials (Basel, Switzerland) · 2026Review
- Nano zinc oxide (ZnO) foliar nutrition improves yield, antioxidant defence, and zinc content in rice grown under Zn-deficient soil.Discover nano · 2026Article
- Nanopriming with zinc oxide nanoparticle boosts seed vigour, photosynthesis, osmolytes accumulation and antioxidant activity in tomato.Scientific reports · 2025Article
- Pre-treatment of Cucurbita maxima 'Hokkaido orange' by Viscum album aqueous extracts in search of allelopathic potential.Scientific reports · 2024Article
- Seed Germination of Three Milk Thistle (Plants (Basel, Switzerland) · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The agriculture sector faces numerous problems. One of the beforementioned problems relates to the proper crop plants’ fertilization. The conventional bulk fertilizers are becoming less effective and have a negative impact on the environment. Nanomaterials such as zinc oxide nanoparticles (ZnO NPs) are widely used in various sectors such as medicine or electronics. Several studies indicate that nano-ZnO may likewise be considered as a potential nanofertilizer. In present research, an attempt was made to study the influence of two different sized ZnO NPs (<50 nm and <100 nm) on the seed germination of chosen tomato (Solanum lycopersicum) cultivars. The seeds of three cherry tomato cultivars were placed on a Petri dish with the NPs suspensions (0, 50, 150, and 250 mg/L) in order to examine the influence on germination parameters at a certain size of NPs and at a chosen concentration. In addition, within this study, we verified that the implicated conditions have the exact impact on all three cultivars. The obtained results indicate that all the factors affect the seed sprouting, however, this process mainly depends on the type of tomato cultivar and the size of the used nanoparticles. The parameter of the germination percentage (GP) was the only of the assumed factors that did not influence it significantly. Nevertheless, the values of other examined parameters such as the MGT, GRI, CVG, or VI depend strongly on all assumed features including the type of chosen cultivar. The obtained results vary significantly between all cultivars which indicates that the plants from the same family may require different conditions for optimal growth. In this research the <50 nm ZnO nanoparticles had more beneficial influence on sprouting parameters then parallelly used <100 nm ZnO nanoparticles.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.